Crispr Infuses First Human in Landmark Gene-Editing Study
Crispr Therapeutics and partner Vertex Pharmaceuticals said on Monday morning that the first patient in a trial using CTX001 received the one-time medicine.
Jio Sets New 4G Availability Record in India, Opensignal Says
Jio's score grew by close to one percentage point to reach 97.5 percent, up from 96.7 percent about six months ago, said the Opensignal's Mobile Network Experience report.
Comments
Post a Comment